PMC:7253482 / 25933-26258 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"830","span":{"begin":72,"end":77},"obj":"Species"},{"id":"831","span":{"begin":55,"end":61},"obj":"Chemical"},{"id":"832","span":{"begin":317,"end":324},"obj":"Chemical"}],"attributes":[{"id":"A830","pred":"tao:has_database_id","subj":"830","obj":"Tax:11676"},{"id":"A831","pred":"tao:has_database_id","subj":"831","obj":"MESH:D011134"},{"id":"A832","pred":"tao:has_database_id","subj":"832","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T143","span":{"begin":72,"end":75},"obj":"Body_part"},{"id":"T144","span":{"begin":288,"end":295},"obj":"Body_part"}],"attributes":[{"id":"A143","pred":"fma_id","subj":"T143","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A144","pred":"fma_id","subj":"T144","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T161","span":{"begin":132,"end":137},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T162","span":{"begin":200,"end":207},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T249","span":{"begin":288,"end":295},"obj":"Chemical"},{"id":"T250","span":{"begin":317,"end":324},"obj":"Chemical"}],"attributes":[{"id":"A249","pred":"chebi_id","subj":"T249","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A250","pred":"chebi_id","subj":"T250","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T81","span":{"begin":132,"end":137},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T82","span":{"begin":200,"end":207},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T60855","span":{"begin":0,"end":2},"obj":"IN"},{"id":"T15145","span":{"begin":3,"end":11},"obj":"NN"},{"id":"T83757","span":{"begin":11,"end":12},"obj":"-COMMA-"},{"id":"T41451","span":{"begin":13,"end":16},"obj":"DT"},{"id":"T95094","span":{"begin":17,"end":21},"obj":"JJ"},{"id":"T76290","span":{"begin":22,"end":30},"obj":"NN"},{"id":"T92271","span":{"begin":31,"end":37},"obj":"NN"},{"id":"T59290","span":{"begin":38,"end":41},"obj":"CC"},{"id":"T46337","span":{"begin":42,"end":45},"obj":"DT"},{"id":"T52476","span":{"begin":46,"end":54},"obj":"VBG"},{"id":"T10675","span":{"begin":55,"end":61},"obj":"NN"},{"id":"T18714","span":{"begin":62,"end":68},"obj":"NN"},{"id":"T37792","span":{"begin":69,"end":71},"obj":"IN"},{"id":"T21845","span":{"begin":72,"end":82},"obj":"NN"},{"id":"T87196","span":{"begin":82,"end":83},"obj":"-COMMA-"},{"id":"T16269","span":{"begin":84,"end":89},"obj":"WDT"},{"id":"T23317","span":{"begin":90,"end":96},"obj":"RB"},{"id":"T90485","span":{"begin":97,"end":108},"obj":"VBZ"},{"id":"T49535","span":{"begin":109,"end":111},"obj":"PRP"},{"id":"T16896","span":{"begin":112,"end":114},"obj":"IN"},{"id":"T63209","span":{"begin":115,"end":123},"obj":"NN"},{"id":"T42025","span":{"begin":124,"end":131},"obj":"NN"},{"id":"T63465","span":{"begin":132,"end":137},"obj":"NN"},{"id":"T4468","span":{"begin":137,"end":138},"obj":"-COMMA-"},{"id":"T1830","span":{"begin":139,"end":146},"obj":"VBZ"},{"id":"T56636","span":{"begin":147,"end":150},"obj":"DT"},{"id":"T80263","span":{"begin":151,"end":162},"obj":"NN"},{"id":"T21297","span":{"begin":163,"end":165},"obj":"IN"},{"id":"T77941","span":{"begin":166,"end":173},"obj":"RB"},{"id":"T47145","span":{"begin":174,"end":186},"obj":"VBG"},{"id":"T48978","span":{"begin":187,"end":207},"obj":"NNS"},{"id":"T78349","span":{"begin":208,"end":218},"obj":"VBN"},{"id":"T84508","span":{"begin":219,"end":221},"obj":"IN"},{"id":"T99687","span":{"begin":222,"end":230},"obj":"NN"},{"id":"T94485","span":{"begin":231,"end":243},"obj":"NN"},{"id":"T8371","span":{"begin":244,"end":247},"obj":"MD"},{"id":"T70765","span":{"begin":248,"end":252},"obj":"RB"},{"id":"T19557","span":{"begin":253,"end":259},"obj":"VB"},{"id":"T68211","span":{"begin":260,"end":263},"obj":"JJ"},{"id":"T58964","span":{"begin":264,"end":266},"obj":"TO"},{"id":"T91845","span":{"begin":267,"end":273},"obj":"JJ"},{"id":"T28724","span":{"begin":274,"end":284},"obj":"NNS"},{"id":"T35775","span":{"begin":285,"end":287},"obj":"IN"},{"id":"T42494","span":{"begin":288,"end":295},"obj":"NN"},{"id":"T48391","span":{"begin":296,"end":303},"obj":"NN"},{"id":"T91764","span":{"begin":304,"end":313},"obj":"NN"},{"id":"T1369","span":{"begin":314,"end":316},"obj":"IN"},{"id":"T1370","span":{"begin":317,"end":324},"obj":"NNS"}],"relations":[{"id":"R70746","pred":"arg1Of","subj":"T1830","obj":"T60855"},{"id":"R57447","pred":"arg2Of","subj":"T15145","obj":"T60855"},{"id":"R82201","pred":"arg1Of","subj":"T1830","obj":"T83757"},{"id":"R18543","pred":"arg1Of","subj":"T92271","obj":"T41451"},{"id":"R93264","pred":"arg1Of","subj":"T92271","obj":"T95094"},{"id":"R8642","pred":"arg1Of","subj":"T92271","obj":"T76290"},{"id":"R7092","pred":"arg1Of","subj":"T92271","obj":"T59290"},{"id":"R24584","pred":"arg2Of","subj":"T18714","obj":"T59290"},{"id":"R72489","pred":"arg1Of","subj":"T18714","obj":"T46337"},{"id":"R76166","pred":"arg1Of","subj":"T18714","obj":"T52476"},{"id":"R37843","pred":"arg1Of","subj":"T18714","obj":"T10675"},{"id":"R59613","pred":"arg1Of","subj":"T18714","obj":"T37792"},{"id":"R69771","pred":"arg2Of","subj":"T21845","obj":"T37792"},{"id":"R38925","pred":"arg1Of","subj":"T18714","obj":"T87196"},{"id":"R46559","pred":"arg1Of","subj":"T18714","obj":"T16269"},{"id":"R78632","pred":"arg1Of","subj":"T90485","obj":"T23317"},{"id":"R80497","pred":"arg1Of","subj":"T18714","obj":"T90485"},{"id":"R82405","pred":"arg2Of","subj":"T49535","obj":"T90485"},{"id":"R44853","pred":"arg1Of","subj":"T90485","obj":"T16896"},{"id":"R46661","pred":"arg2Of","subj":"T63465","obj":"T16896"},{"id":"R81667","pred":"arg1Of","subj":"T63465","obj":"T63209"},{"id":"R13160","pred":"arg1Of","subj":"T63465","obj":"T42025"},{"id":"R63988","pred":"arg1Of","subj":"T1830","obj":"T4468"},{"id":"R82299","pred":"arg1Of","subj":"T59290","obj":"T1830"},{"id":"R71846","pred":"arg2Of","subj":"T19557","obj":"T1830"},{"id":"R93165","pred":"arg1Of","subj":"T80263","obj":"T56636"},{"id":"R55292","pred":"arg1Of","subj":"T80263","obj":"T21297"},{"id":"R1386","pred":"arg2Of","subj":"T48978","obj":"T21297"},{"id":"R1387","pred":"arg1Of","subj":"T47145","obj":"T77941"},{"id":"R1388","pred":"arg1Of","subj":"T48978","obj":"T47145"},{"id":"R1389","pred":"arg2Of","subj":"T48978","obj":"T78349"},{"id":"R1390","pred":"arg1Of","subj":"T78349","obj":"T84508"},{"id":"R1391","pred":"arg2Of","subj":"T94485","obj":"T84508"},{"id":"R1392","pred":"arg1Of","subj":"T94485","obj":"T99687"},{"id":"R1393","pred":"arg1Of","subj":"T80263","obj":"T8371"},{"id":"R1394","pred":"arg2Of","subj":"T19557","obj":"T8371"},{"id":"R1395","pred":"arg1Of","subj":"T19557","obj":"T70765"},{"id":"R1396","pred":"arg1Of","subj":"T80263","obj":"T19557"},{"id":"R1397","pred":"arg1Of","subj":"T58964","obj":"T68211"},{"id":"R1398","pred":"arg1Of","subj":"T19557","obj":"T58964"},{"id":"R1399","pred":"arg2Of","subj":"T28724","obj":"T58964"},{"id":"R1400","pred":"arg1Of","subj":"T28724","obj":"T91845"},{"id":"R20306","pred":"arg1Of","subj":"T28724","obj":"T35775"},{"id":"R1402","pred":"arg2Of","subj":"T91764","obj":"T35775"},{"id":"R1403","pred":"arg1Of","subj":"T91764","obj":"T42494"},{"id":"R1404","pred":"arg1Of","subj":"T91764","obj":"T48391"},{"id":"R22078","pred":"arg1Of","subj":"T91764","obj":"T1369"},{"id":"R1406","pred":"arg2Of","subj":"T1370","obj":"T1369"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T142","span":{"begin":72,"end":75},"obj":"Body_part"},{"id":"T143","span":{"begin":288,"end":295},"obj":"Body_part"}],"attributes":[{"id":"A142","pred":"fma_id","subj":"T142","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A143","pred":"fma_id","subj":"T143","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T167","span":{"begin":288,"end":295},"obj":"Chemical"},{"id":"T168","span":{"begin":317,"end":324},"obj":"Chemical"}],"attributes":[{"id":"A167","pred":"chebi_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A168","pred":"chebi_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T186","span":{"begin":72,"end":75},"obj":"Species"},{"id":"T191","span":{"begin":200,"end":207},"obj":"Species"}],"attributes":[{"id":"A186","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:57667"},{"id":"A187","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:35274"},{"id":"A188","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:12721"},{"id":"A189","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:11709"},{"id":"A190","pred":"ncbi_taxonomy_id","subj":"T186","obj":"NCBItxid:11676"},{"id":"A191","pred":"ncbi_taxonomy_id","subj":"T191","obj":"NCBItxid:10239"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T146","span":{"begin":0,"end":325},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"831","span":{"begin":55,"end":61},"obj":"Chemical"},{"id":"830","span":{"begin":72,"end":77},"obj":"Species"},{"id":"832","span":{"begin":317,"end":324},"obj":"Chemical"}],"attributes":[{"id":"A831","pred":"pubann:denotes","subj":"831","obj":"MESH:D011134"},{"id":"A830","pred":"pubann:denotes","subj":"830","obj":"Tax:11676"},{"id":"A832","pred":"pubann:denotes","subj":"832","obj":"MESH:D011134"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}

{"project":"LitCovid-sentences","denotations":[{"id":"T146","span":{"begin":0,"end":325},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In contrast, the high mutation rate66 and the evolving glycan shield of HIV-120,39, which firmly exemplifies it as “evasion strong” virus, hinders the development of broadly neutralizing antibodies67.Viruses classified as “evasion strong”26,56 may then differ due to varied efficacies of protein surface shielding by glycans."}